Hair Loss: When to See a Dermatologist & What Tests to Ask For

The Core Question: How Soon Is 'Soon Enough'?

The American Academy of Dermatology's guidance on this is unambiguous: see a dermatologist as soon as you notice hair loss. The earlier the cause is identified, the more treatment options remain available — and for some conditions, irreversible follicle loss accumulates with every month of delay.

This guide explains which signs most urgently need professional assessment, exactly what a dermatologist will examine and test, which blood tests are standard (and which you should ask for), and when a scalp biopsy is indicated.

Signs That Mean You Should See a Dermatologist Now

Red Flags — Do Not Wait

These presentations warrant urgent assessment, ideally within days to a couple of weeks:

• Patchy, complete hair loss on the scalp — could indicate alopecia areata (reversible with early treatment) or a scarring alopecia (potentially irreversible without early intervention)
• Scalp redness, scaling, scarring, or follicular plugging — signs of a scarring (cicatricial) alopecia such as lichen planopilaris (LPP) or central centrifugal cicatricial alopecia (CCCA); every week of untreated inflammation destroys more follicles permanently
• Hair loss with systemic symptoms — fever, joint pain, rash, fatigue, or unexplained weight loss alongside hair loss suggests a systemic condition (lupus, thyroid disease, inflammatory bowel disease) that needs prompt medical investigation
• Sudden, severe shedding in a child or teenager — pediatric alopecia has different differential diagnoses and requires specialist evaluation
• Eyebrow or eyelash loss alongside scalp loss — broadens the differential and may indicate alopecia areata, thyroid disease, or other systemic causes

Also Worth Seeing a Dermatologist For

These presentations are not emergencies, but delay is not in your interest:

• Increased daily shedding for more than 2–3 months with no obvious trigger (recent illness, major surgery, childbirth)
• Visible widening of the part line or a thinning crown that has progressed noticeably over 6–12 months
• Diffuse shedding that has not resolved 6 months after a known trigger (postpartum, illness, rapid weight loss)
• Hair shedding after starting a new medication — drug-induced telogen effluvium is common but requires confirmation and a conversation with your prescriber
• A family history of early-onset hair loss combined with a thickening ponytail or visible scalp — early-stage female pattern hair loss responds best to treatment before significant density is lost

What Happens at the Dermatologist Appointment

History and Examination

Before any tests, a thorough history is essential — and it matters more than many patients realize:

• Timeline: When did you first notice increased shedding? Did it begin suddenly or gradually?
• Distribution: Is the whole scalp involved, or specific areas?
• Pattern: Are whole hairs falling out with a white bulb (telogen effluvium pattern) or breaking mid-shaft (traction, chemical, or nutritional damage)?
• Associated symptoms: Scalp itch, tenderness, burning, or visible scalp changes
• Medical history: Thyroid disease, PCOS, recent illness, surgery, or hospitalization
• Drug history: Every medication, supplement, hormonal contraceptive, or herbal product taken in the 3 months before shedding began — this single piece of history is the most important clue for drug-induced hair loss
• Nutritional history: Recent significant dietary restriction or weight loss
• Family history: Pattern baldness in first-degree relatives on either side

The physical examination includes the scalp, the hair shafts themselves, nails (nail pitting and ridging can signal alopecia areata or other systemic conditions), eyebrows, eyelashes, and any other body-hair changes.

The Diagnostic Tests

1. Hair Pull Test

The simplest and most immediate test. The dermatologist grasps approximately 40–60 hairs between thumb and forefinger, applies gentle tension from root to tip, and counts how many hairs come away. Normally, 0–3 hairs per pull is expected.

Six or more hairs per pull indicates active, significant shedding — useful to confirm that a patient's symptoms are real and to gauge severity. The pull test is most informative in telogen effluvium; it may be negative in alopecia areata if the active zone is elsewhere on the scalp.

2. Trichoscopy (Dermoscopy of the Scalp)

A handheld dermatoscope (or dedicated video trichoscope like the Folliscope®) at 10×–100× magnification gives the dermatologist detailed views of follicular openings, hair shaft caliber, and the scalp surface. This non-invasive tool has largely replaced the need for an immediate biopsy in many straightforward cases by allowing pattern recognition:

Trichoscopy provides real-time, non-invasive diagnostic information and also serves as a baseline measurement to track treatment response over subsequent visits.

3. Hair Density and Diameter Measurement

Specialized trichometric analysis can quantify hair density (follicles per cm²) and individual shaft diameter — crucial for documenting baseline and monitoring whether treatment is working over 3–6 months. This may use the Folliscope® or a similar device.

4. The Pull Test on Washed vs. Unwashed Hair

Some dermatologists modify the standard pull test to distinguish a true positive from hygiene artifact: asking patients not to wash hair for 5 days before the appointment, then performing the pull test on dry, unwashed hair increases sensitivity for active shedding.

The Blood Tests — Standard Panel and When to Add More

Blood work cannot diagnose the type of alopecia (that requires clinical and trichoscopic assessment), but it identifies treatable underlying causes that are contributing to or driving the hair loss.

Standard First-Line Panel for Women

Additional Tests — Ask For These When Relevant

The most commonly missed test: Serum ferritin. Standard CBC can be entirely normal while ferritin is critically low. A ferritin level below 30 ng/mL is considered by many dermatologists to be a threshold below which hair loss is more likely, even in the absence of anemia. Always request ferritin specifically, not just a "full blood count."

When a Scalp Biopsy Is Needed

A 4-mm scalp punch biopsy with horizontal sectioning is the gold standard for definitive diagnosis and is particularly critical in one scenario: any suspected scarring (cicatricial) alopecia. In scarring alopecias, follicles are being permanently destroyed by inflammation. Biopsy reveals the pattern and severity of inflammation, guides the choice of treatment (topical corticosteroids, hydroxychloroquine, doxycycline, or newer biologics), and confirms whether the process is still active.

Biopsy may also be indicated when:

• The clinical picture and trichoscopy are inconclusive after several months
• Atypical alopecia areata (the dermoscopic pattern is mixed or confusing)
• Scalp psoriasis or other dermatoses coexist and complicate interpretation
• Response to empirical treatment is absent and the diagnosis needs to be reassessed

Biopsies are not routinely needed for straightforward telogen effluvium, obvious postpartum hair loss with a clear timeline, or female pattern hair loss with a classic trichoscopic appearance.

What to Expect After Diagnosis

If the Diagnosis Is Telogen Effluvium

The priority is identifying and addressing the trigger (nutritional deficiency, thyroid dysfunction, drug, illness). If the trigger has resolved, reassurance and a 6-month monitoring plan are appropriate, along with minoxidil to support regrowth if shedding is severe.

If the Diagnosis Is Female Pattern Hair Loss (FPHL)

Minoxidil (topical or oral) is first-line; additional options include anti-androgens (spironolactone, finasteride), platelet-rich plasma (PRP), and low-level laser therapy. Starting early — before miniaturized hairs are fully lost — gives the best outcomes. See female pattern hair loss guide for full detail.

If the Diagnosis Is Alopecia Areata

Treatment depends on extent and activity. Options range from intralesional corticosteroid injections for limited patches to JAK inhibitors (baricitinib, ritlecitinib — both FDA-approved in 2022–2023) for severe or universal disease. Early treatment of active disease improves outcomes. See alopecia areata guide and JAK inhibitors for alopecia.

If the Diagnosis Is a Scarring Alopecia

Urgent suppression of the inflammatory process is the goal — once follicles are destroyed, regrowth is not possible. Treatment typically includes potent topical or intralesional corticosteroids, hydroxychloroquine, or doxycycline. Regular follow-up (every 3–6 months) to monitor disease activity is mandatory.

How to Make the Most of Your Appointment

• Photograph your scalp before going: Part your hair in multiple places under bright light and take overhead photos. These baselines are invaluable for tracking change over 6–12 months.
• Bring a complete medication list including supplements, vitamins, hormonal contraceptives, and herbal products — ideally covering the past 6 months.
• Note your shedding pattern: When did you first notice it? Has it changed? Do you lose more hair in the shower, or throughout the day?
• Ask explicitly for ferritin if your GP has only run a CBC — it is often omitted and is one of the most actionable deficiencies to correct.
• Ask about trichoscopy: If your dermatologist does not routinely use dermoscopy for scalp assessment, ask whether it is available.

The Bottom Line: Don't Wait

Hair loss is under-investigated and often under-treated. Many women spend months hoping the problem resolves on its own while a correctable deficiency or a treatable condition silently progresses. A single appointment with a board-certified dermatologist can distinguish the reversible from the permanent, identify treatable contributors, and initiate a treatment plan — the earlier, the better.

For understanding the biology underlying these conditions, see the hair growth cycle explained. For specific condition guides within this hub, visit hair loss and thinning.